Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04200443
Title Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University

uterus leiomyosarcoma




Cabozantinib + Temozolomide

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center Recruiting Duarte California 91010 United States Details
Northwestern University Recruiting Chicago Illinois 60611 United States Details
University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City Iowa 52242 United States Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field